BCR and B-cell chronic lymphocytic leukemia: This inhibition of BCR activation hinders the triggering of VLA-4-dependent adhesion of CLL cells to ECM and to endothelium, causing mobilization of neoplastic cells in the bloodstream and interfering with the microenvironment’s protective effects.24